Multicenter Uveitis Steroid Treatment Trial (MUST)

Principal Investigator

Paul Latkany, MD

Enrollment Status

Open  

Objective

The purpose of this study is to examine the efficacy and safety data in patients with intermediate, pan-, or posterior uveitis, comparing systemic therapy vs. Fluocinolone Acetonide (FA) Implant. Primary end point is Visual Acuity.

Eligibility

Contact Principal Investigator

Contact Information  

Principal Investigator: Paul Latkany, MD at (212) 687-0265

 

Home > Current Research > Clinical Trials in Ophthalmology > Multicenter Uveitis Steroid Treatment Trial (MUST)